Literature DB >> 211414

Cellular immune response in genital herpes simplex virus infection.

L Corey, W C Reeves, K K Holmes.   

Abstract

We studied the relations between the cellular immune response, pre-existing complement-fixing antibody and virus type with duration of virus excretion in genital herpes simplex virus (HSV) infection. Thirty-six patients (seven with HSV-1 and 29 with HSV-2) with genital herpes underwent serologic testing, sequential viral cultures and weekly determination of lymphocyte-transformation stimulation index with inactivated HSV antic n. The duration of virus excretion was shortest in those with pre-existing complement-fixing antibody, was unrelated to virus type, and was inversely correlated with the magnitude of the mean peak stimulation index (r = -0.69, P less than 0.001). Prolonged virus excretion occurred in patients with a delayed and diminished peak index. Recurrent episodes had a higher peak index (29.4 compared to 14.5) (P less than 0.02), an earlier development of the peak during recurrences (9.1 vs. 25.8 days) (P less than 0.01) and a briefer duration of viral shedding than initial episodes. Thus, the temporal course and magnitude of the stimulation index correlate with and may determine the duration of genital HSV infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211414     DOI: 10.1056/NEJM197811022991805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  19 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

Review 2.  Herpes latency, meningitis, radiculomyelopathy and disseminated infection.

Authors:  J J Sasadeusz; S L Sacks
Journal:  Genitourin Med       Date:  1994-12

3.  Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.

Authors:  H J Zweerink; D Martinez; R J Lynch; L W Stanton
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

4.  Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.

Authors:  M C Rattray; G M Peterman; L C Altman; L Corey; K K Holmes
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

5.  Genital herpes: hype or hope?

Authors:  M W Alder; A Mindel
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

6.  Cytomegalovirus-specific cell-mediated immunity in lower-socioeconomic-class adolescent women with local cytomegalovirus infections.

Authors:  R G Faix; S E Zweig; J F Kummer; D Moore; D J Lang
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

7.  Immunity to cytopathic agents associated with Crohn's disease: a negative study.

Authors:  M Chiba; L C McLaren; R G Strickland
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

8.  Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody.

Authors:  E W Hook; R E Roddy; S A Lukehart; J Hom; K K Holmes; M R Tam
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

9.  Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.

Authors:  Y Han; Q A Chang; T Virag; N C West; D George; M G Castro; M C Bohn
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

10.  Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.

Authors:  H J Zweerink; L Corey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.